Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
EasyFinder Online Selection Tool from Mettler Toledo
Friday, July 25, 2014
New tool helps customers find the perfect laboratory balances and scales with just a few clicks of their mouse.

Simultaneous Determination of Amlodipine and its Counterion Besylate
Friday, July 18, 2014
Determination of amlodipine and besylate by a simple, rapid, reliable, and accurate HPLC method.

Compact Sample Concentrator for R&D Departments
Tuesday, July 15, 2014
MiniVap™ blowdown sample concentrator from Porvair Sciences.

High Vacuum Benchtop Solvent Evaporator
Friday, July 11, 2014
The EZ-2 Elite Centrifugal Evaporator from Genevac.

Cresset Announces the Release of Forge V10.3
Tuesday, July 08, 2014
Significant new science, visualization and integration for leading ligand-based drug design workbench.

Cresset Announces the Release of Torch V10.3
Tuesday, July 01, 2014
Delivers intuitive visualization and analysis tools for multiple parameter optimization.

Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Monday, June 30, 2014
Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

Easy-to-Understand Introduction to CHN Microanalysis
Saturday, June 21, 2014
A video introduction to Model 440 microanalysis system from Exeter Analytical.

Lonza Innovation Showcase Features Novel Culture System at ISSCR
Saturday, June 21, 2014
Company has introduced L7™ hiPSC reprogramming and hPSC culture system at ISSCR.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1258
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv